| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Public Ltd Co | Chief Accounting Officer | Restricted Stock Units (RSU) | 3.81K | Jan 5, 2023 | Direct | ||
| Horizon Therapeutics Public Ltd Co | Chief Accounting Officer | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | Direct | |
| Horizon Therapeutics Public Ltd Co | Chief Accounting Officer | Restricted Stock Units | 0 | Oct 6, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Public Ltd Co | Oct 6, 2023 | 4 | -$801K | 4 | Oct 6, 2023 | Chief Accounting Officer |
| HZNP | Horizon Therapeutics Public Ltd Co | Jan 4, 2023 | 6 | -$470K | 4 | Jan 6, 2023 | Chief Accounting Officer |
| HZNP | Horizon Therapeutics Public Ltd Co | Nov 11, 2022 | 0 | $0 | 3 | Nov 14, 2022 | Chief Accounting Officer |